The human intestinal microbiome plays a critical role in human health and disease,
including the pathogenesis of inflammatory bowel disease (IBD). Numerous studies have …

In the twenty first century, the changing epidemiology of inflammatory bowel disease (IBD)
globally with increasing disease incidence across many countries relates to the altered gut …

Inflammatory bowel diseases (IBD) are a group of chronic diseases of increasing worldwide
prevalence characterized by gastrointestinal (GI) inflammation leading to debilitating …

Microbial dysbiosis characterized by alterations in the structure and function of the gut
microbiome has long been implicated in the pathogenesis of inflammatory bowel disease …

Inflammatory bowel disease (IBD) has become a global disease with accelerating incidence
worldwide in the 21st century while its accurate etiology remains unclear. In the past …

Studies of the roles of microbial communities in the development of inflammatory bowel
disease (IBD) have reached an important milestone. A decade of genome-wide association …

Our understanding of the microbial involvement in inflammatory bowel disease (IBD)
pathogenesis has increased exponentially over the past decade. The development of newer …

Inflammatory bowel diseases (IBD) arise from a convergence of genetic risk, environmental
factors, and gut microbiota, where each is necessary but not sufficient to cause disease …

Inflammatory bowel disease is a heterogeneous group of chronic disorders that result from
the interaction of the intestinal immune system with the gut microbiome. Until recently, most …

Inflammatory Bowel Disease (IBD) is characterized by prolonged inflammation of the
gastrointestinal tract, which is thought to occur due to dysregulation of the immune system …